X-PAC® Portfolio Expansion
Spinal Fusion
DevelopmentActive
Key Facts
About Expanding Innovations
Expanding Innovations is a private, commercial-stage medical device company specializing in a novel, non-screw-based expandable cage technology for spinal fusion procedures. Its core innovation, the X-PAC® system, relocates the expansion mechanism from the implant to the inserter instrument, designed to provide superior lifting power, tactile feedback, and reduced risk of subsidence. With over 18,000 cages implanted in the U.S., the company has achieved early commercial traction and is planning portfolio expansions for 2026. EI operates in the competitive spine surgery market, targeting the aging population and seeking to address key limitations of traditional expandable cages.
View full company profileTherapeutic Areas
Other Spinal Fusion Drugs
| Drug | Company | Phase |
|---|---|---|
| JAZBI™ Cubes | SDIP Innovations | Preclinical |
| Expandable Interbody Portfolio | Globus Medical | Iterative Development |
| Mimetic Metal Technology Development | CoreLink Surgical | Development/Commercial |
| Bone Graft Substitute | BiologicsMD | Pre-clinical |
| VisuALIF | SpineSmith | Commercial |
| ASTRO Registry | Artoss | Post-Market |
| Hive Smart Implant Exploration | NanoHive Medical | Pre-clinical R&D |
| ProLift Pivot Expandable Spacer System | Life Spine | FDA Cleared |
| NEXXT MATRIXX Clinical Evidence Study | Nexxt Spine | Post-Market Study |
| AGA111 | Angitia Biopharmaceuticals | Phase 3 |
| SOLACE™ | Xenix Medical | Commercial |
| TrellOss Porous Ti Interbody System | HighRidge Medical | Approved |